Kevin Flanagan
About Kevin Flanagan
Kevin Flanagan is the Director of Translational Science at Cofactor Genomics, where he has worked since 2022. He holds a Ph.D. in Molecular Cell Biology from Washington University in St. Louis and has extensive experience in research and development within the genomics field.
Current Role at Cofactor Genomics
Kevin Flanagan serves as the Director of Translational Science at Cofactor Genomics, a position he has held since 2022. In this role, he is responsible for overseeing research initiatives that translate scientific findings into practical applications in genomics. His leadership contributes to the advancement of the company's mission to enhance understanding of the immune system and its role in health and disease.
Previous Experience at Cofactor Genomics
Prior to his current role, Kevin Flanagan worked at Cofactor Genomics from 2017 to 2022 in various capacities. He began as Scientist III and later advanced to Senior Scientist in R&D. During his tenure, he focused on research and development projects that aimed to innovate genomic technologies and improve immune response measurements.
Education and Academic Background
Kevin Flanagan completed his Bachelor of Science in Biological Sciences and Philosophy at the University of Notre Dame from 2007 to 2011. He then pursued a Doctor of Philosophy (Ph.D.) in Molecular Cell Biology at Washington University in St. Louis, where he studied from 2011 to 2017. His educational background provides a strong foundation for his work in translational science.
Research Experience
Kevin Flanagan has extensive research experience, including his role as an Undergraduate Research Associate at the University of Notre Dame from 2008 to 2011. He also participated in a Summer Undergraduate Research Fellowship at the University of Kansas Medical Center in 2009. His research activities have contributed to his expertise in molecular biology and immune response.
Authorship and Publications
Kevin Flanagan authored a blog post focused on measuring immune response to predict outcomes. This publication reflects his engagement with current scientific discussions and his commitment to sharing knowledge within the field of translational science.